Israel World Coronavirus Health Israel

Pfizer/BioNtech to seek approval for third jab

Reading now: 945
www.rte.ie

Pfizer and BioNtech have announced that it will seek regulatory approval for a third dose of their Covid-19 vaccine. The pharmaceutical companies said that, based on drop-offs in efficacy seen in Israel after six months, they believe that a third dose may be needed within six to 12 months after full vaccination. "While protection against severe disease remained high across the full 6 months, a decline in efficacy against symptomatic disease over time and the continued emergence of variants are expected," a statement from the two companies said.

It comes after initial data from a trial showed a third shot pushed antibody levels five to 10 times higher against the original strain and the Beta variant, compared to the first two doses alone,

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA